30 Day Trial

Cerapedics Gains FDA Approval of PMA Supplement for i-FACTOR

FDA approved Cerapedics' Premarket Approval supplement for i-FACTOR® Peptide Enhanced Bone Graft for use in ACDF to treat degenerative cervical disc disease.

Active Implants' NUsurface Artificial Meniscus Available in Israel

Two patients in Israel have undergone knee surgery with Active Implants' NUsurface® Meniscus Implant, the first artificial meniscus to be marketed in the Middle East.

Paragon 28 Launches Sterile Kit for TenoTac Fixation

Paragon 28 launched a sterile kit configuration for the TenoTac® Soft Tissue Fixation System for hammertoe and plantar plate repair.

OrthoPediatrics Launches PediFoot Deformity Correction in the U.S.

OrthoPediatrics commenced commercial U.S. launch of the PediFoot Deformity Correction System.

Medicrea Growth Driven by U.S. Sales of Patient-Specific Implants

Medicrea reports 3Q19 revenue of €8.2MM (USD $9.2MM), +12.3% vs. 3Q18.

aap Sales Decline on U.S. Distribution Loss

aap Implantate reports 3Q19 revenue of €2.8MM (USD $3.1MM), -0.1% vs. 3Q18.

NextStep Arthropedix Adds Blade Femoral Stem to iNSitu Hip

NextStep Arthropedix launched The Blade™, a femoral stem component for the iNSitu™ Total Hip system.

Personalized Stem Cells Clinical Trial Update

Personalized Stem Cells treated the first patients in an FDA-approved clinical trial for stem cell treatment of knee osteoarthritis.

SI-BONE Continues Growth with Reimbursement Wins

SI-BONE reports 3Q19 revenue of USD $16.2MM, +20.9% vs. 3Q18.

Wright Medical Growth Downturn Continued in Lead Up to Stryker Deal

Wright Medical reports 3Q19 revenue of USD $212.4MM, +9.4% vs. 3Q18.

 



It's important to know that ORTHOFLASH (like many ORTHOWORLD resources) is included with Membership. The full menu of Membership benefits is outlined on this pageStill have questions? Or, would you prefer personal attention?
Fran Bursic welcomes your inquiry by phone at 440.543.2101 or via 
email.

Read more from ORTHOWORLD: